Guardant Health
GH
#1530
Rank
NZ$23.40 B
Marketcap
NZ$180.19
Share price
2.11%
Change (1 day)
189.28%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): NZ-$5.54

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is NZ-$5.55. In 2024 the company made an earnings per share (EPS) of NZ-$6.16 an increase over its 2023 EPS that were of NZ-$7.40.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$5.54-9.98%
2024NZ-$6.16-16.82%
2023NZ-$7.40-33.13%
2022NZ-$11.0760%
2021NZ-$6.9255.04%
2020NZ-$4.46207.14%
2019NZ-$1.45-19.81%
2018NZ-$1.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
NZ-$3.70-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
NZ-$8.32 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA